EP1452868A2
(de)
|
2003-02-27 |
2004-09-01 |
Pepscan Systems B.V. |
Verfahren zur Selektion eines potenziellen Arzneimittels
|
US7598356B2
(en)
|
2004-07-08 |
2009-10-06 |
Board of Regents of the University of Nebraska by and on behalf of the University of Nebraska Medical Center |
Method for purifying a protein of the cystine-knot superfamily
|
DK1844337T3
(da)
*
|
2005-01-24 |
2013-09-30 |
Pepscan Systems Bv |
Bindingsforbindelser, immunogene forbindelser og peptidmimetika
|
WO2008013454A2
(en)
*
|
2006-07-26 |
2008-01-31 |
Pepscan Systems B.V. |
Immunogenic compounds and protein mimics
|
AU2007333846B2
(en)
|
2006-12-14 |
2014-01-23 |
Aileron Therapeutics, Inc. |
Bis-sulfhydryl macrocyclization systems
|
US7981998B2
(en)
*
|
2006-12-14 |
2011-07-19 |
Aileron Therapeutics, Inc. |
Bis-sulfhydryl macrocyclization systems
|
ES2558928T3
(es)
|
2007-01-31 |
2016-02-09 |
Dana-Farber Cancer Institute, Inc. |
Péptidos p53 estabilizados y usos de los mismos
|
CN109627287A
(zh)
|
2007-02-23 |
2019-04-16 |
爱勒让治疗公司 |
三唑大环系统
|
US8592377B2
(en)
|
2007-03-28 |
2013-11-26 |
President And Fellows Of Harvard College |
Stitched polypeptides
|
WO2008127136A1
(en)
*
|
2007-04-12 |
2008-10-23 |
Dmitry Gennadievich Tovbin |
Method of determination of protein ligand binding and of the most probable ligand pose in protein binding site
|
AT506150B1
(de)
|
2007-12-12 |
2010-01-15 |
Apeptico Forschung Und Entwick |
Zyklisches und cystein-freies peptid
|
AT506151B1
(de)
|
2007-12-12 |
2010-01-15 |
Apeptico Forschung Und Entwick |
Fusionsprotein
|
EP2653545A1
(de)
*
|
2008-02-05 |
2013-10-23 |
Bicycle Therapeutics Limited |
Verfahren und Zusammensetzungen
|
CA2744088A1
(en)
|
2009-01-14 |
2010-07-22 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
GB0913775D0
(en)
*
|
2009-08-06 |
2009-09-16 |
Medical Res Council |
Multispecific peptides
|
EP2393832B1
(de)
|
2009-02-06 |
2015-07-08 |
Pepscan Systems BV |
Verkürzte cystin-knoten-proteine
|
GB0914110D0
(en)
*
|
2009-08-12 |
2009-09-16 |
Medical Res Council |
Peptide libraries
|
US20130072439A1
(en)
|
2009-09-22 |
2013-03-21 |
Huw M. Nash |
Peptidomimetic macrocycles
|
GB201012410D0
(en)
|
2010-07-23 |
2010-09-08 |
Medical Res Council |
Intracellular immunity
|
JP2013535514A
(ja)
|
2010-08-13 |
2013-09-12 |
エイルロン セラピューティクス,インコーポレイテッド |
ペプチド模倣大環状分子
|
GB201013980D0
(en)
|
2010-08-20 |
2010-10-06 |
Ecole Polytech |
Bicyclic uPA inhibitors
|
WO2012051405A1
(en)
|
2010-10-13 |
2012-04-19 |
Bristol-Myers Squibb Company |
Methods for preparing macrocycles and macrocycle stabilized peptides
|
WO2012057624A1
(en)
|
2010-10-25 |
2012-05-03 |
Pepscan Systems B.V. |
Novel bicyclic peptide mimetics
|
WO2012083078A2
(en)
|
2010-12-15 |
2012-06-21 |
The Research Foundation Of State University Of New York |
Croos-linked peptides and proteins, methods of making same, and uses thereof
|
CN102095874A
(zh)
*
|
2011-01-05 |
2011-06-15 |
盛世泰科生物医药技术(苏州)有限公司 |
一种生物素标记探针联合蛋白芯片寻找小分子化学药靶点的方法
|
CN102095875A
(zh)
*
|
2011-01-05 |
2011-06-15 |
盛世泰科生物医药技术(苏州)有限公司 |
一种点击化学技术与荧光染料探针联合蛋白芯片寻找小分子化学药靶点的方法
|
EP2726101B1
(de)
|
2011-06-30 |
2018-08-08 |
Genzyme Corporation |
Inhibitoren der t-zellen-aktivierung
|
LT3299377T
(lt)
|
2011-10-07 |
2021-03-25 |
Bicyclerd Limited |
Struktūrizuoto polipeptido specifiškumo moduliavimas
|
GB201117428D0
(en)
|
2011-10-07 |
2011-11-23 |
Bicycle Therapeutics Ltd |
Structured polypeptides with sarcosine linkers
|
TW201806968A
(zh)
|
2011-10-18 |
2018-03-01 |
艾利倫治療公司 |
擬肽巨環化合物
|
IN2014MN01384A
(de)
|
2011-12-19 |
2015-04-03 |
Janssen R & D Ireland |
|
GB201202268D0
(en)
|
2012-02-09 |
2012-03-28 |
Medical Res Council |
Intracellular immunity
|
CN104159595A
(zh)
|
2012-02-15 |
2014-11-19 |
爱勒让治疗公司 |
拟肽大环化合物
|
WO2013123267A1
(en)
|
2012-02-15 |
2013-08-22 |
Aileron Therapeutics, Inc. |
Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
|
US9238676B2
(en)
|
2012-05-17 |
2016-01-19 |
Ra Pharmaceuticals, Inc. |
Peptide and peptidomimetic inhibitors
|
US9556229B2
(en)
*
|
2012-05-18 |
2017-01-31 |
The Regents Of The University Of California |
Modification of peptides using a bis(thioether)arylbridge approach
|
MX2015005244A
(es)
|
2012-11-01 |
2015-07-14 |
Aileron Therapeutics Inc |
Aminoacidos disustituidos y metodos de preparacion y el uso de los mismos.
|
US10267788B1
(en)
*
|
2013-02-01 |
2019-04-23 |
National Technology & Engineering Solutions Of Sandia, Llc |
Linear peptides that mimic structural epitopes for antibody assays
|
GB201306623D0
(en)
|
2013-04-11 |
2013-05-29 |
Bicycle Therapeutics Ltd |
Modulation of structured polypeptide specificity
|
GB201313352D0
(en)
|
2013-07-26 |
2013-09-11 |
Isis Innovation |
Identification of peptide ligands
|
GB201318728D0
(en)
|
2013-10-23 |
2013-12-04 |
Mologic Ltd |
Detection of cleavage activity of an enzyme
|
WO2015063465A2
(en)
|
2013-10-28 |
2015-05-07 |
Bicycle Therapeutics Limited |
Novel polypeptides
|
AU2015320549A1
(en)
|
2014-09-24 |
2017-04-13 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|
JP2018503595A
(ja)
|
2014-09-24 |
2018-02-08 |
エルロン・セラピューティクス・インコーポレイテッドAileron Therapeutics,Inc. |
ペプチド模倣大環状分子およびその製剤
|
JP6882978B2
(ja)
|
2014-10-29 |
2021-06-02 |
バイスクルアールディー・リミテッド |
Mt1−mmpに特異的な二環性ペプチドリガンド
|
BR112017019738A2
(pt)
|
2015-03-20 |
2018-05-29 |
Aileron Therapeutics Inc |
macrociclos peptidomiméticos e usos dos mesmos
|
ES2901273T3
(es)
|
2015-04-06 |
2022-03-21 |
Subdomain Llc |
Polipéptidos que contienen dominios de unión de novo y usos de los mismos
|
TWI751110B
(zh)
*
|
2015-06-24 |
2022-01-01 |
荷蘭商科林生物醫療有限責任公司 |
Aml抗原及其用途
|
US10059741B2
(en)
|
2015-07-01 |
2018-08-28 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
US10023613B2
(en)
|
2015-09-10 |
2018-07-17 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles as modulators of MCL-1
|
KR20180101483A
(ko)
|
2016-01-08 |
2018-09-12 |
에임 쎄라퓨틱스 비.브이. |
치료적 항-cd9 항체
|
GB201600903D0
(en)
|
2016-01-18 |
2016-03-02 |
Bicycle Therapeutics Ltd |
Peptide derivaties
|
GB201600911D0
(en)
|
2016-01-18 |
2016-03-02 |
Bicycle Therapeutics Ltd |
Stabilized peptide derivatives
|
GB201607827D0
(en)
|
2016-05-04 |
2016-06-15 |
Bicycle Therapeutics Ltd |
Bicyclic peptide-toxin conjugates specific for MT1-MMP
|
US11566047B2
(en)
|
2016-08-10 |
2023-01-31 |
Tokyo University Of Pharmacy & Life Sciences |
Peptide or pharmaceutically acceptable salt thereof, or prodrug thereof
|
GB201618432D0
(en)
*
|
2016-11-01 |
2016-12-14 |
Matn Scient Ltd |
Detection and treatment of demyelinating diseases
|
WO2018096365A1
(en)
|
2016-11-27 |
2018-05-31 |
Bicyclerd Limited |
Methods for treating cancer
|
AU2017371472A1
(en)
*
|
2016-12-06 |
2019-06-27 |
Stichting Voor De Technische Wetenschappen |
Multicyclic peptides and methods for their preparation
|
CN110506049A
(zh)
|
2016-12-23 |
2019-11-26 |
拜斯科技术开发有限公司 |
用于结合mt1-mmp的肽配体
|
US11730819B2
(en)
|
2016-12-23 |
2023-08-22 |
Bicycletx Limited |
Peptide derivatives having novel linkage structures
|
WO2018127699A1
(en)
|
2017-01-06 |
2018-07-12 |
Bicyclerd Limited |
Compounds for treating cancer
|
GB201706477D0
(en)
|
2017-04-24 |
2017-06-07 |
Bicycle Therapeutics Ltd |
Modification of polypeptides
|
WO2018197893A1
(en)
|
2017-04-27 |
2018-11-01 |
Bicycletx Limited |
Bicyclic peptide ligands and uses thereof
|
CA3064512A1
(en)
|
2017-06-09 |
2018-12-13 |
Vib Vzw |
Glutamine dehydrogenase inhibitors for use in muscle regeneration
|
JP7301757B2
(ja)
|
2017-06-26 |
2023-07-03 |
バイスクルアールディー・リミテッド |
検出可能部分を持つ二環式ペプチドリガンドおよびその使用
|
WO2019016123A1
(en)
|
2017-07-17 |
2019-01-24 |
Vib Vzw |
TARGETING SYNAPTOGYRIN-3 IN THE TREATMENT OF TAUOPATHY
|
JP2020529427A
(ja)
|
2017-08-04 |
2020-10-08 |
バイスクルテクス・リミテッド |
Cd137に対して特異的な二環式ペプチドリガンド
|
US20200283482A1
(en)
|
2017-08-14 |
2020-09-10 |
Bicyclerd Limited |
Bicyclic peptide ligand prr-a conjugates and uses thereof
|
US20200291096A1
(en)
|
2017-08-14 |
2020-09-17 |
Bicyclerd Limited |
Bicyclic peptide ligand sting conjugates and uses thereof
|
JP7317815B2
(ja)
|
2017-10-19 |
2023-07-31 |
シュレーディンガー インコーポレイテッド |
代替コアを有する化合物の活性セットを予測する方法、およびそれを伴う創薬方法
|
WO2019081714A1
(en)
|
2017-10-26 |
2019-05-02 |
Vib Vzw |
POSITIVE MACROPHAGES TO PODOPLANIN
|
MX2020004935A
(es)
|
2017-11-14 |
2020-09-25 |
Arcellx Inc |
Terapias con celulas inmunitarias multifuncionales.
|
US11377482B2
(en)
|
2017-11-14 |
2022-07-05 |
Arcellx, Inc. |
D-domain containing polypeptides and uses thereof
|
US11464803B2
(en)
|
2017-11-14 |
2022-10-11 |
Arcellx, Inc. |
D-domain containing polypeptides and uses thereof
|
TWI825046B
(zh)
|
2017-12-19 |
2023-12-11 |
英商拜西可泰克斯有限公司 |
Epha2特用之雙環胜肽配位基
|
GB201721265D0
(en)
|
2017-12-19 |
2018-01-31 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for EphA2
|
WO2019158579A1
(en)
|
2018-02-13 |
2019-08-22 |
Vib Vzw |
Targeting minimal residual disease in cancer with rxr antagonists
|
CN111902429A
(zh)
*
|
2018-02-23 |
2020-11-06 |
拜斯科技术开发有限公司 |
多聚体双环肽配体
|
AU2019247795A1
(en)
|
2018-04-04 |
2020-11-12 |
Bicycletx Limited |
Heterotandem bicyclic peptide complexes
|
GB201808835D0
(en)
|
2018-05-30 |
2018-07-11 |
Bicyclerd Ltd |
Ligands and methods of selecting binding targets for such
|
GB201810320D0
(en)
|
2018-06-22 |
2018-08-08 |
Bicycletx Ltd |
Peptide ligands for binding to CD38
|
GB201810329D0
(en)
|
2018-06-22 |
2018-08-08 |
Bicycletx Ltd |
Peptide ligands for binding to integrin avB3
|
GB201810327D0
(en)
|
2018-06-22 |
2018-08-08 |
Bicycletx Ltd |
Peptide ligands for binding to IL-17
|
GB201810316D0
(en)
|
2018-06-22 |
2018-08-08 |
Bicyclerd Ltd |
Peptide ligands for binding to EphA2
|
US11180531B2
(en)
|
2018-06-22 |
2021-11-23 |
Bicycletx Limited |
Bicyclic peptide ligands specific for Nectin-4
|
JP2022512779A
(ja)
|
2018-10-23 |
2022-02-07 |
バイスクルテクス・リミテッド |
二環式ペプチドリガンドおよびその使用
|
GB201819659D0
(en)
|
2018-12-03 |
2019-01-16 |
Vib Vzw |
Cancer regression by inducing a regeneration-like reponse
|
GB201820295D0
(en)
|
2018-12-13 |
2019-01-30 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for MT1-MMP
|
GB201820320D0
(en)
|
2018-12-13 |
2019-01-30 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for FAPalpha
|
SG11202106081YA
(en)
|
2018-12-13 |
2021-07-29 |
Bicycletx Ltd |
Bicyclic peptide ligands specific for mt1-mmp
|
GB201820316D0
(en)
|
2018-12-13 |
2019-01-30 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for IL-17
|
GB201820325D0
(en)
|
2018-12-13 |
2019-01-30 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for psma
|
US20220088207A1
(en)
|
2018-12-21 |
2022-03-24 |
Bicycletx Limited |
Bicyclic peptide ligands specific for pd-l1
|
GB201900530D0
(en)
|
2019-01-15 |
2019-03-06 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for CD38
|
GB201900526D0
(en)
|
2019-01-15 |
2019-03-06 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for caix
|
GB201900528D0
(en)
|
2019-01-15 |
2019-03-06 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for integrin AVB3
|
WO2020165600A1
(en)
|
2019-02-14 |
2020-08-20 |
Bicycletx Limited |
Bicyclic peptide ligand sting conjugates and uses thereof
|
GB201902458D0
(en)
|
2019-02-22 |
2019-04-10 |
Mologic Ltd |
Treatment stratification for an excerbation of inflamation
|
US20220135614A1
(en)
|
2019-03-04 |
2022-05-05 |
Bicyclerd Limited |
Synthesis of bicycle toxin conjugates, and intermediates thereof
|
GB2582571B
(en)
|
2019-03-25 |
2024-02-28 |
Syntherix Ltd |
Peptides and use thereof
|
KR20220007098A
(ko)
|
2019-05-09 |
2022-01-18 |
바이사이클티엑스 리미티드 |
Ox40에 특이적인 이환식 펩티드 리간드
|
EP3976067A1
(de)
|
2019-05-28 |
2022-04-06 |
Vib Vzw |
Cd8+-t-zellen ohne plexine und ihre anwendung zur krebsbehandlung
|
WO2020239945A1
(en)
|
2019-05-28 |
2020-12-03 |
Vib Vzw |
Cancer treatment by targeting plexins in the immune compartment
|
US20220315554A1
(en)
*
|
2019-07-08 |
2022-10-06 |
3B Pharmaceuticals Gmbh |
Compounds comprising a fibroblast activation protein ligand and use thereof
|
EP3763726A1
(de)
*
|
2019-07-08 |
2021-01-13 |
3B Pharmaceuticals GmbH |
Verbindungen mit fibroblasten-aktivierendem proteinligand und deren verwendung
|
MX2022000252A
(es)
*
|
2019-07-08 |
2022-02-21 |
3B Pharmaceuticals Gmbh |
Compuestos que comprenden un ligando de proteina de activacion de fibroblasto y uso del mismo.
|
TW202118770A
(zh)
|
2019-07-30 |
2021-05-16 |
英商拜西可泰克斯有限公司 |
異質雙環肽複合物
|
US20220363713A1
(en)
|
2019-08-07 |
2022-11-17 |
Belyntic GmbH |
A method for modification of peptides immobilized on a solid support by traceless reductively cleavable linker molecules
|
CN114787197A
(zh)
|
2019-08-13 |
2022-07-22 |
拜斯科技术开发有限公司 |
修饰的多聚双环肽配体
|
GB201912320D0
(en)
|
2019-08-28 |
2019-10-09 |
Bicycletx Ltd |
PBP Binding Bicyclic Peptide Ligands
|
GB201914233D0
(en)
|
2019-10-02 |
2019-11-13 |
Bicyclerd Ltd |
Phage cyclisation assay
|
JP2022551607A
(ja)
|
2019-10-03 |
2022-12-12 |
バイスクルテクス・リミテッド |
ヘテロタンデム二環式ペプチド複合体
|
GB201914872D0
(en)
|
2019-10-15 |
2019-11-27 |
Bicycletx Ltd |
Bicyclic peptide ligand drug conjugates
|
WO2021123767A1
(en)
|
2019-12-16 |
2021-06-24 |
Bicycletx Limited |
Bicyclic peptide ligands specific for il-17
|
GB201918558D0
(en)
|
2019-12-16 |
2020-01-29 |
Bicycle Tx Ltd |
Bicyclic peptide ligands specific for IL-17
|
GB201918557D0
(en)
|
2019-12-16 |
2020-01-29 |
Bicycle Tx Ltd |
Bicyclic peptide ligands specific for IL-17
|
GB201918559D0
(en)
|
2019-12-16 |
2020-01-29 |
Bicycle Tx Ltd |
Bicyclic peptide ligands specific for IL-17
|
GB202002706D0
(en)
|
2020-02-26 |
2020-04-08 |
Bicycletx Ltd |
Pbp3 binding bicyclic peptide ligands
|
GB202002705D0
(en)
|
2020-02-26 |
2020-04-08 |
Bicycletx Ltd |
Anti-infective bicyclic peptide conjugates
|
JP2023520714A
(ja)
|
2020-04-06 |
2023-05-18 |
バイスクルテクス・リミテッド |
Tslpに特異的な二環式ペプチドリガンド
|
WO2021220011A1
(en)
|
2020-05-01 |
2021-11-04 |
Bicycletx Limited |
Anti-infective bicyclic peptide conjugates
|
JP2023526067A
(ja)
|
2020-05-15 |
2023-06-20 |
バイスクルテクス・リミテッド |
抗感染性二環式ペプチドリガンド
|
WO2022063957A1
(en)
|
2020-09-24 |
2022-03-31 |
Vib Vzw |
Biomarker for anti-tumor therapy
|
EP4216943A1
(de)
|
2020-09-24 |
2023-08-02 |
Vib Vzw |
Kombination von p2y6-inhibitoren und immuncheckpoint-inhibitoren
|
GB202016331D0
(en)
|
2020-10-15 |
2020-12-02 |
Bicyclerd Ltd |
Bicyclic peptide ligand drug conjugates
|
WO2022148971A1
(en)
|
2021-01-08 |
2022-07-14 |
Bicycletx Limited |
Anti-infective bicyclic peptide ligands
|
EP4274839A1
(de)
|
2021-01-08 |
2023-11-15 |
BicycleTx Limited |
Antiinfektiöse bicyclische peptidliganden
|
CN117120459A
(zh)
|
2021-01-08 |
2023-11-24 |
拜斯科技术开发有限公司 |
抗感染双环肽配体
|
JP2024504068A
(ja)
|
2021-01-08 |
2024-01-30 |
バイスクルテクス・リミテッド |
抗感染性二環式ペプチドリガンド
|
CA3206529A1
(en)
|
2021-01-08 |
2022-07-14 |
Bicycletx Limited |
Heterotandem bicyclic peptide complexes
|
US20240083944A1
(en)
|
2021-01-08 |
2024-03-14 |
Bicycle TX Limited |
Anti-infective bicyclic peptide ligands
|
AU2022206395A1
(en)
|
2021-01-11 |
2023-08-17 |
Bicycletx Limited |
Methods for treating cancer
|
AU2022209878A1
(en)
*
|
2021-01-19 |
2023-09-07 |
The Council Of The Queensland Institute Of Medical Research |
Novel bicyclic peptides
|
CA3211257A1
(en)
|
2021-02-17 |
2022-08-25 |
Vib Vzw |
Inhibition of slc4a4 in the treatment of cancer
|
WO2022199804A1
(en)
|
2021-03-24 |
2022-09-29 |
Vib Vzw |
Nek6 inhibition to treat als and ftd
|
WO2023031623A2
(en)
|
2021-09-03 |
2023-03-09 |
Bicycletx Limited |
Synthesis of bicycle toxin conjugates, and intermediates thereof
|
GB202114282D0
(en)
|
2021-10-06 |
2021-11-17 |
Bicyclerd Ltd |
Bicyclic peptide ligand drug conjugates
|
GB202114279D0
(en)
|
2021-10-06 |
2021-11-17 |
Bicycletx Ltd |
Bicyclic peptide ligand drug conjugates
|
EP4170347A1
(de)
*
|
2021-10-25 |
2023-04-26 |
3B Pharmaceuticals GmbH |
Rezeptorliganden des gastroinhibitorischen peptids
|
GB202116266D0
(en)
|
2021-11-11 |
2021-12-29 |
Bicycletx Ltd |
Novel use
|
WO2023139292A1
(en)
|
2022-01-24 |
2023-07-27 |
Cambridge Enterprise Limited |
Tau therapy
|
WO2024009108A1
(en)
|
2022-07-07 |
2024-01-11 |
Bicycletx Limited |
Anti-infective bicyclic peptide ligands
|